The protocol below summarizes a general research-style dilution approach for subcutaneous measurement using standard U-100 insulin syringes
Nat Metab (2022) 4:389403
As research progresses, the hope is that some of these biologic modalities will enter clinical practice, especially in high-stakes surgeries (transplantation, cardiac surgery, major trauma) where current supportive care is not always sufficient to prevent organ injury
Consequently, BCL-2 family inhibitors have been identified to function as senolytics, including ABT-737, ABT-263 (Navitoclax), A-1331852, and A-1155463
Any consideration of BPC-157 should involve caution and awareness that it remains an experimental compound Formula CzHseNsO22 Molar Mass 1419.556 g/mol CAS No 137525-51-0 Synonyms BPC-157 Research purpose only